Limei M. Chen

Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey.

Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey.

Journal: Acta haematologica

Published: April 29, 2024

Clinical and genetic characteristics of young patients with myeloproliferative neoplasms

Clinical and genetic characteristics of young patients with myeloproliferative neoplasms

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: June 25, 2023

Meta-pharmacokinetic analysis of posaconazole following dosing of oral suspension, delayed-release tablet, and intravenous infusion in patients vs. healthy volunteers: Impact of clinical characteristics and race.

Meta-pharmacokinetic analysis of posaconazole following dosing of oral suspension, delayed-release tablet, and intravenous infusion in patients vs. healthy volunteers: Impact of clinical characteristics and race.

Journal: International journal of antimicrobial agents

Published: June 02, 2023

Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms.

Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms.

Journal: Acta haematologica

Published: May 19, 2022

A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma.

A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma.

Journal: Journal of cancer research and clinical oncology

Published: April 19, 2022

Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms

Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 20, 2022

Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasms.

Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasms.

Journal: Leukemia & lymphoma

Published: June 08, 2021

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients.

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients.

Journal: Frontiers in cardiovascular medicine

Published: March 16, 2021

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial.

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial.

Journal: Trials

Published: February 01, 2019

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.

Journal: Trials

Published: August 29, 2017

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.

Journal: Journal of translational medicine

Published: August 19, 2017

Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.

Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.

Journal: International journal of hematology

Published: May 03, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026